Sun Pharmaceutical Industries Ltd. is the mainstay of the Indian pharmaceutical industry and one of India’s most respected drug manufacturers in the world. From low-cost generic drugs to specialist drugs, Sun Pharma plays a critical role in global healthcare. Founded in 1983, the company has grown up to be the No.1 pharmaceutical brand in India as per market leadership. If you are interested in knowing the net worth, owner details, CEO and market capitalization of Sun Pharmaceutical, this article explains everything in simple and clear terms.
Company Overview
Sun Pharma is an established global specialty generic pharmaceuticals company having a strong presence in the developed as well as emerging markets. The company furnishes quality medicines to more than 100 countries and has a robust manufacturing and research network.
| Company Detail | Information |
| Company Name | Sun Pharmaceutical Industries Ltd. |
| Founded | 1983 |
| Country of Origin | India |
| Industry | Pharmaceuticals |
| Founder | Dilip Shanghvi |
| Global Revenue | US$ 6.2 Billion |
| Manufacturing Units | 41 facilities |
| Employees | 43,000+ worldwide |
| Presence | 100+ countries |
Sun Pharma manufactures medicines in both chronic and acute therapy such as generics, branded generics, specialty drugs, OTC products, API’s and intermediates. The company supplies billions of doses annually in important therapy areas such as cardiology, diabetology, oncology, dermatology, neurology and respiratory care.
Who Owns Sun Pharmaceutical?
Dilip Shanghvi and his family own Sun Pharmaceutical Industries Ltd. The Shanghvi family owns Orient Investment, a controlling stake of about 54.48% in the company. Dilip Shanghvi grew Sun Pharma from a small startup company to an international health giant using long-term vision and disciplined growth. As of 2025, Dilip Shanghvi’s personal net worth is estimated to be around $28.9 billion and allows him to be one of the richest people in India.
Who Leads Sun Pharmaceutical?
Sun Pharma is a company with experienced leadership. Dilip Shanghvi is the Executive Chairman in which he has his focus on the strategic direction and specialty growth. Kirti Ganorkar is the Managing Director who took charge in September 2025. Together, they drive the company’s innovation strategy, global growth and long-term sustainability.
Sun Pharmaceutical Net Worth and Market Capitalization
Sun Pharma is among the largest pharmaceutical companies in the world. The company currently holds a market capitalization of around ₹3,62,851 crore, which is a testament to the investor’s confidence and the company’s stable business performance. With global revenue of US $6.2 billion, Sun Pharma continues to consolidate its financial position through innovation, specialty medicines and global penetration.
Why Sun Pharmaceutical Stands Out
Sun Pharma is among the best because they have a high focus on innovation and research. The company spends between 6-8% of its global revenue on R&D every year and has more than 2,900 research professionals. Sun Pharma is also a leader in the complex and specialty products like inhalers, liposomal formulations, controlled release formulations, and injectable formulations.
Its global footprint, trusted quality, diversified portfolio and ethical business practices make Sun Pharma a trusted healthcare partner in the global Market. With one Sun Pharma medicine prescribed every minute, the company continues to make a difference and improve access to quality healthcare across the world.
